Emerging Infectious Diseases (Jun 2003)

Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001

  • Timothy H. Holtz,
  • Joel Ackelsberg,
  • Jacob L. Kool,
  • Richard Rosselli,
  • Anthony Marfin,
  • Thomas Matte,
  • Sara T. Beatrice,
  • Michael B. Heller,
  • Dan Hewett,
  • Linda Moskin,
  • Michel L. Bunning,
  • Marcelle Layton

DOI
https://doi.org/10.3201/eid0906.020668
Journal volume & issue
Vol. 9, no. 6
pp. 689 – 696

Abstract

Read online

On October 31, 2001, in New York City, a 61-year-old female hospital employee who had acquired inhalational anthrax died after a 6-day illness. To determine sources of exposure and identify additional persons at risk, the New York City Department of Health, Centers for Disease Control and Prevention, and law enforcement authorities conducted an extensive investigation, which included interviewing contacts, examining personal effects, summarizing patient’s use of mass transit, conducting active case finding and surveillance near her residence and at her workplace, and collecting samples from co-workers and the environment. We cultured all specimens for Bacillus anthracis. We found no additional cases of cutaneous or inhalational anthrax. The route of exposure remains unknown. All environmental samples were negative for B. anthracis. This first case of inhalational anthrax during the 2001 outbreak with no apparent direct link to contaminated mail emphasizes the need for close coordination between public health and law enforcement agencies during bioterrorism-related investigations.

Keywords